Spinelab Raises CHF4.7M in Series C Financing
Spinelab, a Winterthur, Switzerland-based developer of motion preserving stabilization systems for the spine, has raised CHF4.7m (approximately $4.9m) in Series C financing.
The company intends to use the capital to initiate commercial activities in Europe and to complete the development of its second core product. Spinelab’s core product is Elaspine™, a pedicle screw based posterior motion preservation system for thoracolumbar spine.
The company is led by President & CEO Thomas Zehnder and Chairman Gerard Moufflet.